KEGG   PATHWAY: hsa04810Help
Entry
hsa04810                    Pathway                                

Name
Regulation of actin cytoskeleton - Homo sapiens (human)
Class
Cellular Processes; Cell motility
BRITE hierarchy
Pathway map
Regulation of actin cytoskeleton
hsa04810

All organismsOrtholog table
Disease
H00255  
Hypogonadotropic hypogonadism
H00480  
Non-syndromic X-linked mental retardation
H00484  
Other brachydactylies
H00569  
Aarskog-Scott syndrome
H00578  
MYH9-related kidney diseases
H00586  
Epidermolysis bullosa, junctional
H00590  
Congenital muscular dystrophies (CMD/MDC)
H00626  
Nephrotic syndrome and focal segmental glomerulosclerosis
H00627  
Premature ovarian failure
H00642  
Lacrimo-auriculo-dento-digital syndrome (LADD)
H00698  
Nemaline myopathy
H00801  
Familial thoracic aortic aneurysm and dissection (TAAD)
H00845  
Familial amyloidosis
H00865  
Lethal congenital contractural syndrome (LCCS)
H00956  
Lattice corneal dystrophies (LCD)
H00957  
Fleck corneal dystrophy (FCD)
H00997  
CATSHL syndrome
H01025  
Familial adenomatous polyposis
H01193  
Familial tumoral calcinosis (FTC)
H01207  
Trigonocephaly
H01255  
Juvenile-onset dystonia
H01260  
Glomerulopathy with fibronectin deposits (GFND)
Drug
D00113  
Atropine (USP)
D00138  
Scopolamine (INN)
D00181  
Argatroban hydrate (JP16)
D00525  
Pilocarpine (JAN/USP)
D01840  
Fasudil hydrochloride (JAN)
D01981  
Ximelagatran (JAN/USAN/INN)
D02200  
Pilocarpine hydrochloride (JP16/USP)
D03065  
Becaplermin (USAN/INN)
D03115  
Fasudil hydrochloride hydrate (JAN)
D03136  
Bivalirudin (USAN/INN)
D03692  
Desirudin (USAN/INN)
D03722  
Efegatran sulfate (USAN)
D03728  
Napsagatran (USAN)
D03959  
Efalizumab (USAN/INN)
D04492  
Icatibant acetate (USAN)
D05478  
Pilocarpine nitrate (USP)
D06319  
Volociximab (USAN)
D06880  
Lepirudin (INN)
D07082  
Dabigatran etexilate methanesulfonate (JAN)
D07143  
Melagatran (INN)
D07941  
Fasudil (INN)
D08878  
Brivanib alaninate (JAN/USAN/INN)
D09342  
Etaracizumab (USAN/INN)
D09589  
Brivanib (USAN)
D09939  
Olaratumab (USAN/INN)
D10018  
Necitumumab (USAN/INN)
D10028  
Valategrast hydrochloride (USAN)
Other DBs
BSID: 
GO: 
Organism
Homo sapiens (human) [GN:hsa]
Gene
2147  
F2; coagulation factor II (thrombin) [KO:K01313] [EC:3.4.21.5]
2149  
F2R; coagulation factor II (thrombin) receptor [KO:K03914]
929  
CD14; CD14 molecule [KO:K04391]
3630  
INS; insulin [KO:K04526]
1950  
EGF; epidermal growth factor [KO:K04357]
2246  
FGF1; fibroblast growth factor 1 (acidic) [KO:K04358]
2247  
FGF2; fibroblast growth factor 2 (basic) [KO:K04358]
2248  
FGF3; fibroblast growth factor 3 [KO:K04358]
2249  
FGF4; fibroblast growth factor 4 [KO:K04358]
8822  
FGF17; fibroblast growth factor 17 [KO:K04358]
2251  
FGF6; fibroblast growth factor 6 [KO:K04358]
2252  
FGF7; fibroblast growth factor 7 [KO:K04358]
2253  
FGF8; fibroblast growth factor 8 (androgen-induced) [KO:K04358]
2254  
FGF9; fibroblast growth factor 9 [KO:K04358]
2255  
FGF10; fibroblast growth factor 10 [KO:K04358]
2256  
FGF11; fibroblast growth factor 11 [KO:K04358]
2257  
FGF12; fibroblast growth factor 12 [KO:K04358]
2258  
FGF13; fibroblast growth factor 13 [KO:K04358]
2259  
FGF14; fibroblast growth factor 14 [KO:K04358]
8823  
FGF16; fibroblast growth factor 16 [KO:K04358]
2250  
FGF5; fibroblast growth factor 5 [KO:K04358]
8817  
FGF18; fibroblast growth factor 18 [KO:K04358]
9965  
FGF19; fibroblast growth factor 19 [KO:K04358]
26281  
FGF20; fibroblast growth factor 20 [KO:K04358]
26291  
FGF21; fibroblast growth factor 21 [KO:K04358]
27006  
FGF22; fibroblast growth factor 22 [KO:K04358]
8074  
FGF23; fibroblast growth factor 23 [KO:K04358]
5154  
PDGFA; platelet-derived growth factor alpha polypeptide [KO:K04359]
5155  
PDGFB; platelet-derived growth factor beta polypeptide [KO:K17386]
56034  
PDGFC; platelet derived growth factor C [KO:K05450]
80310  
PDGFD; platelet derived growth factor D [KO:K05450]
3645  
INSRR; insulin receptor-related receptor [KO:K05086] [EC:2.7.10.1]
1956  
EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
2260  
FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]
2263  
FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]
2261  
FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]
2264  
FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]
5156  
PDGFRA; platelet-derived growth factor receptor, alpha polypeptide [KO:K04363] [EC:2.7.10.1]
5159  
PDGFRB; platelet-derived growth factor receptor, beta polypeptide [KO:K05089] [EC:2.7.10.1]
2335  
FN1; fibronectin 1 [KO:K05717]
3672  
ITGA1; integrin, alpha 1 [KO:K06480]
3673  
ITGA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) [KO:K06481]
3674  
ITGA2B; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [KO:K06476]
3675  
ITGA3; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) [KO:K06482]
3676  
ITGA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) [KO:K06483]
3678  
ITGA5; integrin, alpha 5 (fibronectin receptor, alpha polypeptide) [KO:K06484]
3655  
ITGA6; integrin, alpha 6 [KO:K06485]
3679  
ITGA7; integrin, alpha 7 [KO:K06583]
8516  
ITGA8; integrin, alpha 8 [KO:K06584]
3680  
ITGA9; integrin, alpha 9 [KO:K06585]
8515  
ITGA10; integrin, alpha 10 [KO:K06586]
22801  
ITGA11; integrin, alpha 11 [KO:K06587]
3685  
ITGAV; integrin, alpha V [KO:K06487]
3683  
ITGAL; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1 [KO:K05718]
3684  
ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) [KO:K06461]
3687  
ITGAX; integrin, alpha X (complement component 3 receptor 4 subunit) [KO:K06462]
3681  
ITGAD; integrin, alpha D [KO:K06594]
3682  
ITGAE; integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1 [KO:K06524]
3688  
ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) [KO:K05719]
3689  
ITGB2; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) [KO:K06464]
3690  
ITGB3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) [KO:K06493]
3691  
ITGB4; integrin, beta 4 [KO:K06525]
3693  
ITGB5; integrin, beta 5 [KO:K06588]
3694  
ITGB6; integrin, beta 6 [KO:K06589]
3695  
ITGB7; integrin, beta 7 [KO:K06590]
3696  
ITGB8; integrin, beta 8 [KO:K06591]
623  
BDKRB1; bradykinin receptor B1 [KO:K03915]
624  
BDKRB2; bradykinin receptor B2 [KO:K03916]
1128  
CHRM1; cholinergic receptor, muscarinic 1 [KO:K04129]
1129  
CHRM2; cholinergic receptor, muscarinic 2 [KO:K04130]
1131  
CHRM3; cholinergic receptor, muscarinic 3 [KO:K04131]
1132  
CHRM4; cholinergic receptor, muscarinic 4 [KO:K04132]
1133  
CHRM5; cholinergic receptor, muscarinic 5 [KO:K04133]
2768  
GNA12; guanine nucleotide binding protein (G protein) alpha 12 [KO:K04346]
10672  
GNA13; guanine nucleotide binding protein (G protein), alpha 13 [KO:K04639]
55970  
GNG12; guanine nucleotide binding protein (G protein), gamma 12 [KO:K04347]
648044  
guanine nucleotide binding protein (G protein); K04347 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
2245  
FGD1; FYVE, RhoGEF and PH domain containing 1 [KO:K05720]
89846  
FGD3; FYVE, RhoGEF and PH domain containing 3 [KO:K05722]
5747  
PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]
9564  
BCAR1; breast cancer anti-estrogen resistance 1 [KO:K05726]
1398  
CRK; v-crk avian sarcoma virus CT10 oncogene homolog [KO:K04438]
1399  
CRKL; v-crk avian sarcoma virus CT10 oncogene homolog-like [KO:K04438]
1793  
DOCK1; dedicator of cytokinesis 1 [KO:K13708]
6714  
SRC; v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog [KO:K05704] [EC:2.7.10.2]
6654  
SOS1; son of sevenless homolog 1 (Drosophila) [KO:K03099]
6655  
SOS2; son of sevenless homolog 2 (Drosophila) [KO:K03099]
3265  
HRAS; Harvey rat sarcoma viral oncogene homolog [KO:K02833]
3845  
KRAS; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
4893  
NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO:K07828]
6237  
RRAS; related RAS viral (r-ras) oncogene homolog [KO:K07829]
22800  
RRAS2; related RAS viral (r-ras) oncogene homolog 2 [KO:K07830]
22808  
MRAS; muscle RAS oncogene homolog [KO:K07831]
9459  
ARHGEF6; Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 [KO:K05729]
5290  
PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
5293  
PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
5291  
PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
5294  
PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
5295  
PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha) [KO:K02649]
23533  
PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5 [KO:K02649]
5296  
PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta) [KO:K02649]
8503  
PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma) [KO:K02649]
10451  
VAV3; vav 3 guanine nucleotide exchange factor [KO:K05730]
7409  
VAV1; vav 1 guanine nucleotide exchange factor [KO:K05730]
7410  
VAV2; vav 2 guanine nucleotide exchange factor [KO:K05730]
7074  
TIAM1; T-cell lymphoma invasion and metastasis 1 [KO:K05731]
369  
ARAF; v-raf murine sarcoma 3611 viral oncogene homolog [KO:K08845] [EC:2.7.11.1]
673  
BRAF; v-raf murine sarcoma viral oncogene homolog B [KO:K04365] [EC:2.7.11.1]
5894  
RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 [KO:K04366] [EC:2.7.11.1]
4342  
MOS; v-mos Moloney murine sarcoma viral oncogene homolog [KO:K04367] [EC:2.7.11.1]
5604  
MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
5605  
MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
5594  
MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
5595  
MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
9138  
ARHGEF1; Rho guanine nucleotide exchange factor (GEF) 1 [KO:K12330]
23365  
ARHGEF12; Rho guanine nucleotide exchange factor (GEF) 12 [KO:K07532]
2909  
ARHGAP35; Rho GTPase activating protein 35 [KO:K05732]
387  
RHOA; ras homolog family member A [KO:K04513]
5879  
RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO:K04392]
5880  
RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) [KO:K07860]
5881  
RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) [KO:K07861]
998  
CDC42; cell division cycle 42 [KO:K04393]
5058  
PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 [KO:K04409] [EC:2.7.11.1]
5062  
PAK2; p21 protein (Cdc42/Rac)-activated kinase 2 [KO:K04410] [EC:2.7.11.1]
5063  
PAK3; p21 protein (Cdc42/Rac)-activated kinase 3 [KO:K05733] [EC:2.7.11.1]
10298  
PAK4; p21 protein (Cdc42/Rac)-activated kinase 4 [KO:K05734] [EC:2.7.11.1]
56924  
PAK6; p21 protein (Cdc42/Rac)-activated kinase 6 [KO:K05735] [EC:2.7.11.1]
57144  
PAK7; p21 protein (Cdc42/Rac)-activated kinase 7 [KO:K05736] [EC:2.7.11.1]
8874  
ARHGEF7; Rho guanine nucleotide exchange factor (GEF) 7 [KO:K13710]
28964  
GIT1; G protein-coupled receptor kinase interacting ArfGAP 1 [KO:K05737]
6093  
ROCK1; Rho-associated, coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]
9475  
ROCK2; Rho-associated, coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]
4638  
MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]
85366  
MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]
91807  
MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]
340156  
MYLK4; myosin light chain kinase family, member 4 [KO:K00907] [EC:2.7.11.18]
5499  
PPP1CA; protein phosphatase 1, catalytic subunit, alpha isozyme [KO:K06269] [EC:3.1.3.16]
5500  
PPP1CB; protein phosphatase 1, catalytic subunit, beta isozyme [KO:K06269] [EC:3.1.3.16]
5501  
PPP1CC; protein phosphatase 1, catalytic subunit, gamma isozyme [KO:K06269] [EC:3.1.3.16]
4659  
PPP1R12A; protein phosphatase 1, regulatory subunit 12A [KO:K06270]
4660  
PPP1R12B; protein phosphatase 1, regulatory subunit 12B [KO:K12329]
54776  
PPP1R12C; protein phosphatase 1, regulatory subunit 12C [KO:K17457]
4633  
MYL2; myosin, light chain 2, regulatory, cardiac, slow [KO:K10351]
4636  
MYL5; myosin, light chain 5, regulatory [KO:K12753]
58498  
MYL7; myosin, light chain 7, regulatory [KO:K12754]
10398  
MYL9; myosin, light chain 9, regulatory [KO:K12755]
93408  
MYL10; myosin, light chain 10, regulatory [KO:K12756]
103910  
MYL12B; myosin, light chain 12B, regulatory [KO:K12757]
10627  
MYL12A; myosin, light chain 12A, regulatory, non-sarcomeric [KO:K12757]
29895  
MYLPF; myosin light chain, phosphorylatable, fast skeletal muscle [KO:K12758]
1729  
DIAPH1; diaphanous-related formin 1 [KO:K05740]
1730  
DIAPH2; diaphanous-related formin 2 [KO:K05741]
6548  
SLC9A1; solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 [KO:K05742]
23396  
PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase, type I, gamma [KO:K00889] [EC:2.7.1.68]
8394  
PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase, type I, alpha [KO:K00889] [EC:2.7.1.68]
8395  
PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase, type I, beta [KO:K00889] [EC:2.7.1.68]
79837  
PIP4K2C; phosphatidylinositol-5-phosphate 4-kinase, type II, gamma [KO:K00920] [EC:2.7.1.149]
5305  
PIP4K2A; phosphatidylinositol-5-phosphate 4-kinase, type II, alpha [KO:K00920] [EC:2.7.1.149]
8396  
PIP4K2B; phosphatidylinositol-5-phosphate 4-kinase, type II, beta [KO:K00920] [EC:2.7.1.149]
200576  
PIKFYVE; phosphoinositide kinase, FYVE finger containing [KO:K00921] [EC:2.7.1.150]
3984  
LIMK1; LIM domain kinase 1 [KO:K05743] [EC:2.7.11.1]
3985  
LIMK2; LIM domain kinase 2 [KO:K05744] [EC:2.7.11.1]
81624  
DIAPH3; diaphanous-related formin 3 [KO:K05745]
10458  
BAIAP2; BAI1-associated protein 2 [KO:K05627]
55740  
ENAH; enabled homolog (Drosophila) [KO:K05746]
7454  
WAS; Wiskott-Aldrich syndrome [KO:K05747]
8976  
WASL; Wiskott-Aldrich syndrome-like [KO:K05747]
10163  
WASF2; WAS protein family, member 2 [KO:K05748]
23191  
CYFIP1; cytoplasmic FMR1 interacting protein 1 [KO:K05749]
26999  
CYFIP2; cytoplasmic FMR1 interacting protein 2 [KO:K05749]
10787  
NCKAP1; NCK-associated protein 1 [KO:K05750]
3071  
NCKAP1L; NCK-associated protein 1-like [KO:K05750]
10152  
ABI2; abl-interactor 2 [KO:K05751]
55845  
BRK1; BRICK1, SCAR/WAVE actin-nucleating complex subunit [KO:K05752]
8936  
WASF1; WAS protein family, member 1 [KO:K05753]
10092  
ARPC5; actin related protein 2/3 complex, subunit 5, 16kDa [KO:K05754]
81873  
ARPC5L; actin related protein 2/3 complex, subunit 5-like [KO:K05754]
10093  
ARPC4; actin related protein 2/3 complex, subunit 4, 20kDa [KO:K05755]
10094  
ARPC3; actin related protein 2/3 complex, subunit 3, 21kDa [KO:K05756]
10095  
ARPC1B; actin related protein 2/3 complex, subunit 1B, 41kDa [KO:K05757]
10552  
ARPC1A; actin related protein 2/3 complex, subunit 1A, 41kDa [KO:K05757]
10109  
ARPC2; actin related protein 2/3 complex, subunit 2, 34kDa [KO:K05758]
60  
ACTB; actin, beta [KO:K05692]
71  
ACTG1; actin, gamma 1 [KO:K05692]
345456  
PFN3; profilin 3 [KO:K05759]
5216  
PFN1; profilin 1 [KO:K05759]
5217  
PFN2; profilin 2 [KO:K05759]
375189  
PFN4; profilin family, member 4 [KO:K05759]
5829  
PXN; paxillin [KO:K05760]
7430  
EZR; ezrin [KO:K08007]
5962  
RDX; radixin [KO:K05762]
4478  
MSN; moesin [KO:K05763]
7114  
TMSB4X; thymosin beta 4, X-linked [KO:K05764]
9087  
TMSB4Y; thymosin beta 4, Y-linked [KO:K05764]
1072  
CFL1; cofilin 1 (non-muscle) [KO:K05765]
1073  
CFL2; cofilin 2 (muscle) [KO:K05765]
54434  
SSH1; slingshot protein phosphatase 1 [KO:K05766] [EC:3.1.3.48 3.1.3.16]
54961  
SSH3; slingshot protein phosphatase 3 [KO:K05766] [EC:3.1.3.48 3.1.3.16]
85464  
SSH2; slingshot protein phosphatase 2 [KO:K05766] [EC:3.1.3.48 3.1.3.16]
7414  
VCL; vinculin [KO:K05700]
8826  
IQGAP1; IQ motif containing GTPase activating protein 1 [KO:K16848]
10788  
IQGAP2; IQ motif containing GTPase activating protein 2 [KO:K05767]
128239  
IQGAP3; IQ motif containing GTPase activating protein 3 [KO:K05767]
2934  
GSN; gelsolin [KO:K05768]
85477  
SCIN; scinderin [KO:K05768]
87  
ACTN1; actinin, alpha 1 [KO:K05699]
88  
ACTN2; actinin, alpha 2 [KO:K05699]
89  
ACTN3; actinin, alpha 3 [KO:K05699]
81  
ACTN4; actinin, alpha 4 [KO:K05699]
324  
APC; adenomatous polyposis coli [KO:K02085]
10297  
APC2; adenomatosis polyposis coli 2 [KO:K02085]
50649  
ARHGEF4; Rho guanine nucleotide exchange factor (GEF) 4 [KO:K05769]
4627  
MYH9; myosin, heavy chain 9, non-muscle [KO:K10352]
4628  
MYH10; myosin, heavy chain 10, non-muscle [KO:K10352]
79784  
MYH14; myosin, heavy chain 14, non-muscle [KO:K10352]
Compound
C00306  
Bradykinin
C00338  
Lipopolysaccharide
C01996  
Acetylcholine
C04637  
1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate
C05981  
Phosphatidylinositol-3,4,5-trisphosphate
C11554  
1-Phosphatidyl-1D-myo-inositol 3,4-bisphosphate
Reference
  Authors
Burridge K, Wennerberg K.
  Title
Rho and Rac take center stage.
  Journal
Cell 116:167-79 (2004)
Reference
  Authors
Schmitz AA, Govek EE, Bottner B, Van Aelst L.
  Title
Rho GTPases: signaling, migration, and invasion.
  Journal
Exp Cell Res 261:1-12 (2000)
Reference
  Authors
Takai Y, Sasaki T, Matozaki T.
  Title
Small GTP-binding proteins.
  Journal
Physiol Rev 81:153-208 (2001)
Reference
  Authors
Pollard TD.
  Title
The cytoskeleton, cellular motility and the reductionist agenda.
  Journal
Nature 422:741-5 (2003)
Reference
  Authors
Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR.
  Title
Cell migration: integrating signals from front to back.
  Journal
Science 302:1704-9 (2003)
Reference
  Authors
Sastry SK, Burridge K.
  Title
Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics.
  Journal
Exp Cell Res 261:25-36 (2000)
Reference
  Authors
Fukata M, Nakagawa M, Kuroda S, Kaibuchi K.
  Title
Cell adhesion and Rho small GTPases.
  Journal
J Cell Sci 112 ( Pt 24):4491-500 (1999)
KO pathway
 

DBGET integrated database retrieval system